Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 106OTHER_GOV 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Thrombosis 1Pain, Postoperative 1Inflammation 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Dexmedetomidine × Clear all
NCT07445451 2026-03-03

TURBT

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Phase NA Completed
93 enrolled
Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT06993740 2025-06-15

DEXFLAP

Dharmais National Cancer Center Hospital

Phase NA Recruiting
60 enrolled

Inflammation, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡